The relaxin family peptide receptors (RXFP) 1 and 2 are targets for the relaxin family peptides relaxin and insulin-like peptide 3 (INSL3), respectively. Although both receptors and peptides share a high degree of sequence identity, the cAMP signaling pathways activated by the two systems are quite distinct. Relaxin activation of RXFP1 initially results in accumulation of cAMP via G␣ s , but this is modulated by inhibition of cAMP through G␣ oB . Over time, RXFP1 recruits coupling to G␣ i3 , causing additional cAMP accumulation via a G␣ i3 -G␥-phosphoinositide 3-kinase (PI3K)-protein kinase C (PKC) pathway. In contrast, INSL3 activation of RXFP2 results in accumulation of cAMP only via G␣ s , modulated by cAMP inhibition through G␣ oB . Thus, the aim of this study was to identify the cause of differential G-protein coupling between these highly similar receptors. Construction of chimeric receptors revealed that G␣ i3 coupling is dependent upon the transmembrane region of RXFP1 and independent of the receptor ectodomain or ligand bound. Generation of C-terminal truncated receptors identified the terminal 10 amino acids of the RXFP1 C terminus as essential for G␣ i3 signaling, and point mutations revealed an obligatory role for Arg 752 . RXFP1-mediated G␣ i3 , but not G␣ s or G␣ oB , signaling was also found to be dependent upon membrane rafts, and RXFP1 coupled to G␣ i3 after only 3 min of receptor stimulation. Therefore, RXFP1 coupling to the G␣ i3 -G␥-PI3K-PKC pathway requires the terminal 10 amino acids of the RXFP1 C terminus and membrane raft localization, and the observed delay in this pathway occurs downstream of G␣ i3 .The relaxin family peptides are two-chain hormones that diverged from insulin during early vertebrate evolution (Hsu, 2003;Wilkinson et al., 2005). The family encompasses seven peptides in humans: relaxin-1, relaxin (equivalent to other species' relaxin-1), relaxin-3, and the insulin/relaxin-like peptides INSL3, INSL4, INSL5, and INSL6. All peptides within this family evolved from an ancestral RLN3 (relaxin-3) gene (Hsu, 2003;Wilkinson et al., 2005), but have distinct functional profiles: relaxin was initially identified as a hormone of pregnancy (Hisaw, 1926), but is now credited with roles in the cardiovascular, renal and central nervous systems and in allergic responses. Relaxin-3 is principally expressed in the brain with roles in appetite regulation and anxiety; INSL3 is responsible for testis descent in men and for germ cell survival in both men and women (for review, see van der Westhuizen et al., 2008).